Poster Abstractsusing the same samples. We obtained a highly correlated Ct valuesbetween multiplex and single-plex RT reactions using standard qPCRassays for miRNA expression. For the same samples, the micr<strong>of</strong>luidictechnology (Fluidigm 48.48 dynamic array systems) resulted in a leftshifttowards lower Ct values compared to those observed by standardTaqMan (ABI 7900HT, mean difference, 3.79). In addition, as little as10ng total RNA was sufficient to reproducibly detect up to 96 miRNAsat a wide range <strong>of</strong> expression values using a single 96-multiplexingRT reaction in either FFPE or FF samples. Comparison <strong>of</strong> miRNAsexpression values measured by micr<strong>of</strong>luidic technology with thoseobtained by other array and Next Generation sequencing platformsshowed positive concordance using the same samples but revealedsignificant differences for a large fraction <strong>of</strong> miRNA targets. The qPCRarraybased micr<strong>of</strong>luidic technology can be used in conjunction withmultiplexed RT reactions for miRNA gene expression pr<strong>of</strong>iling. Thisapproach is highly reproducible and the results correlate closely withthe existing singleplex qPCR platform while achievingmuch higherthroughput atlower sample input and reagent usage. It is a rapid, costeffective, customizable array platform for miRNA expression pr<strong>of</strong>ilingand validation. However, comparison <strong>of</strong> miRNA expression usingdifferent platforms requires caution and the use <strong>of</strong> multiple platforms.162 Apollo 200 Fully Integrated DNAHID System: Multi Channel Results inUnder 2 HoursS. Jovanuvich, O. El-Sissi, H. Franklin, B. Nielsen,S. Pagano, R. Belcinski, G. BogdanIntegneX, Inc, Pleasanton, CA, United StatesThe ideal solution to meet the requirements <strong>of</strong> modern humanidentification is an automated, DNA-based hu man identificationsystem that processes samples rap idly and at low cost. IntegenX Inc.will describe the Apollo 200 DNA HID System. The Apollo200 isthe first fully automated sample-to-answer system for STR based HID.The system is based on integration <strong>of</strong> the company’s proprietary andpatented technologies as well as its rapid in-house micr<strong>of</strong>luidic chipprototyping. Reagents in disposable cartridges are loaded on thesystem with up to four buccal swab samples, the sample processing isinitiat ed and a CODIS compatible pr<strong>of</strong>ile is ready in less than two hourswith no further user interaction. The Apollo 200 integrates all <strong>of</strong> thesample handling steps starting from buccal swab(s) or blood, throughcell lysis, DNA extraction, amplification, separation, and detection.Further, the system uses rapid PCR chemistry, on-board capillaryelectrophoresis, and integrated la ser induced fluorescence detection.Initial data from testing conducted by IntegenX and customers will beshown. **Apollo 200 is a trademark <strong>of</strong> IntegenX, Inc.163 Transcriptome Analysis Using Next-Generation Sequencing TechnologyK. Bramlett, K. Lea, L. Qu, P. Whitley,J. Schageman, J. GuLife Technologies, Carlsbad, CA, United StatesHigh throughput RNA sequencing (RNA-Seq) is becoming increasinglyutilized as the technology <strong>of</strong> choice to detect and quantify known andnovel transcripts. Multiple next-generation sequencing (NGS) platformsare available that enable transcriptome pr<strong>of</strong>iling through RNA-Seqworkflows. Demonstrations <strong>of</strong> the power <strong>of</strong> RNA-Seq to pr<strong>of</strong>ile thewell annotated transcriptome and also identify novel transcribedregions, gene fusions, and even identify novel classes <strong>of</strong> RNA arerapidly increasing in the field <strong>of</strong> RNA research. Our aim has been todevelop library preparation methods and tools that aid in the reliablegeneration <strong>of</strong> libraries for next generation sequencing from total RNA.Reported here are results from the development <strong>of</strong> the Ambion®RNA-Seq Library Construction kit optimized for sequencing on theIllumina® next generation sequencing instruments. We show resultsfrom two protocols utilizing the same reagents that allow generation<strong>of</strong> RNA-Seq libraries targeting either the small RNA fraction <strong>of</strong> totalRNA, or the whole transcriptome which includes transcripts larger than100 base pairs. Results are reported from Illumina® Genome AnalyzerII sequencing <strong>of</strong> both small RNA and transcriptome libraries with afocus on mapping to the miRBase and RefSeq references respectively.We also demonstrate the use <strong>of</strong> External RNA Control Consortium(ERCC) transcripts as spike-in controls for transcriptome librariesthat aid in quality control <strong>of</strong> the library generation procedure andaid in downstream data analysis. The library construction technologyembedded in the Ambion® RNA-Seq Library Construction kit enablesresearchers to analyze the transcriptome <strong>of</strong> their research samples ina precise, sensitive and robust manner while maintaining informationregarding the genomic DNA strand to which the RNA transcript mapsutilizing the Illumina® Genome Analyzer II sequencing platform. Theworkflow and results reported here demonstrate new commerciallyavailable options for library construction enabling small RNA andtranscriptome pr<strong>of</strong>iling and novel discovery using next-generationsequencing technology.164 A Case Study: Molecular Pr<strong>of</strong>iling <strong>of</strong>Breast Cancer from Formalin-Fixed,Archival Material — Gene ExpressionPr<strong>of</strong>iles from FFPE Samples withImproved RNA DecrosslinkingTechnologyR. Jaggi 1 , S. Quabius 2 , G. Krupp 31University Bern, Bern, Switzerland; 2 UKSHUniversity Klinik, Kiel, Germany; 3 AmpTec GmbH,Hamburg, GermanyWe have developed a novel demodifaction/decrosslinking protocolfor RNA recovery from archival (FFPE) material. The resulting FFPERNA quality is superior to RNA obtained with other commercialFFPE RNA isolation kits: larger RNAs can be recovered, and RTqPCRdata demonstrate less variability and lower Cq values. ThisFFPE RNA is suitable for differential gene expression measurementby qPCR, high concordance with parallel RNA samples from freshfrozentissues was observed. Prognosis <strong>of</strong> breast cancer is determinedby clinicopathological and molecular factors. We developed andvalidated molecular scores reflecting the hormone status (ER, PGR,HER2 scores) and the proliferation status (PRO score) <strong>of</strong> breast cancercells. The scores can be combined to an overall RISK score. Molecularscores are independent prognostic parameters, they were validated inpostmenopausal patients with estrogen receptor positive breast cancer.Multivariate analysis revealed that PRO and RISK scores outperformconventional parameters (histological grading and Ki-67 labelingindex). Molecular scores are based on routine pathological material,testing can be implemented easily into routine diagnosis.78 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine
165 Benchmarking miRNA ExpressionLevels in Degraded RNA SamplesUsing Real-Time RT-qPCR andMicroarray TechnologiesJ. Holbrook 5 , S.V. Chittur 1 , S. Tighe 2 , V. Nadell 3 ,R. Carmica 4 , K. Sol-Church 5 , A.T. Yeung 61State University <strong>of</strong> New York at Albany, Albany,NY, United States; 2 University <strong>of</strong> Vermont,Burlington, VT, United States; 3 Ohio University,Athens, OH, United States; 4 The University <strong>of</strong>Texas Medical Branch, Galveston, TX, UnitedStates; 5 Nemours/A.I. duPont Hospital for Children,Wilmington, DE, United States; 6 Fox Chase CancerCenter, Philadelphia, PA, United StatesThe Nucleic Acid Research Group (NARG) has conducted experimentsto determine the impact <strong>of</strong> RNA integrity and priming strategies oncDNA synthesis and Real-Time RT-qPCR. As a continuation <strong>of</strong> the RNAintegrity theme, this year’s study was expanded to evaluate the impact<strong>of</strong> RNA integrity on priming strategies for the analysis <strong>of</strong> nine miRNAtargets using Real-Time RT-qPCR. The nine targets were selectedbased on data obtained by the Microarray Research Group (MARG)and represent groups <strong>of</strong> miRNAs that are expressed at low, medium, orhigh levels in the First Choice human brain reference RNA sample. Thetwo RT-qPCR priming strategies tested in this study include the miRNATaqMan assay (Megaplex) <strong>of</strong> ABI and the RT2 miRNA qPCR assay <strong>of</strong>Qiagen/SA Biosciences. The basis for the ABI assay design is a targetspecificstem-loop structure and reverse-transcription primer, whilethe Qiagen design combines poly (A) tailing and a universal reversetranscription in one cDNA synthesis reaction. For this study to assessboth RT methods, samples that were used as templates were humanbrain reference RNA that has been subjected to controlled degradationusing RNase A to RIN (RNA Integrity Number) values <strong>of</strong> 7 (good), 4(moderately degraded), and 2 (severely degraded). In addition tothis Real-Time RT-qPCR data, the same RNA templates were furtheranalyzed using universal poly (A) tailing followed by hybridizationto Affymetrix miRNA GeneChips. We present some insights into RTpriming strategies for miRNA and contrasts qPCR results obtained usingdifferent technologies.168 MicroRNA Analysis Using RNAExtracted from Matched Formalin-Fixed Paraffin-Embedded (FFPE) andFresh Frozen Samples on SOLiD TMSystemK. Lea, J. Gu, E. Zeringer, S. Heater, J. Schageman,C. Mueller, K. BramlettLife Technologies, Carlsbad, CA, United StatesArchived formalin-fixed paraffin-embedded (FFPE) specimensrepresent excellent resources for biomarker discovery, but it has beena major challenge to study gene expression in these samples due tomRNA degradation and modification during fixation and processing.MicroRNAs (miRNAs) regulate gene expression at post-transcriptionallevel and are considered as important regulators <strong>of</strong> cancer progression.Next generation sequencing technologies such as SOLiD TM providean ideal method for measuring the abundance <strong>of</strong> miRNA moleculesin different cancer stages and provide insightful information ontumorigenesis. However, currently there is no good method tosystematically study miRNA expression in FFPE samples on nextgeneration sequencing platforms. We have designed and developeda ligation-based miRNA detection method to capture small RNAsequences in FFPE samples and convert them into templates suitablefor sequencing on the SOLiD TM System. Total RNA was isolated frommatched lung adenocarcinoma FFPE and snap frozen tissues using anAmbion RecoverAll TM kit. A PureLink TM miRNA Isolation kit was usedto enrich the small RNA fraction in these total RNA samples. Librarypreparation using a SOLiD TM Total RNA-Seq kit with modified protocolwas performed on the enriched RNA followed by sequencing onSOLiD TM system. Our results show that small RNA extracted from FFPEsamples was successfully converted to small RNA libraries. Very similarmapping statistics were obtained from matched FFPE and fresh-frozensamples after SOLiD TM sequencing. A good correlation <strong>of</strong> miRNAexpression pattern was also observed. This suggests that miRNAmolecules are less affected by sample degradation and RNA-proteincrosslink. This study provides a foundation for miRNA expressionanalysis on SOLiD TM system using FFPE samples in cancer and otherdiseases.**169 Structural Insights into theMechanism <strong>of</strong> microRNA ModulatedViral TranslationS. Patel 2 , E.A. Pham 1 , P. Pang 1 , M.A. Winters 1 ,M. Eckart 2 , J.S. Glenn 1,31Department <strong>of</strong> Medicine, Stanford UniversitySchool <strong>of</strong> Medicine, Stanford, CA, United States;2Protein and Nucleic Acid Core Facility, StanfordUniversity School <strong>of</strong> Medicine, Stanford, CA, UnitedStates; 3 Palo Alto Veterans Administration MedicalCenter, Palo Alto, CA, United StatesMicroRNAs (miRNAs) are small non-coding regulatory RNAs that controla vast array <strong>of</strong> cellular processes by repressing mRNA translation. LiverexpressedmiR-122 is a miRNA that has been co-opted by hepatitis Cvirus (HCV) to enhance viral translation. Recently, miR-122 antagomirtherapy in non-human primates has been shown to suppress HCVviremia; this pro<strong>of</strong>-<strong>of</strong>-concept study demonstrates the considerablepotential <strong>of</strong> this novel antiviral strategy. The mechanism by which miR-122 modulates HCV translation, however, is unclear. To examine thestructural changes that miR-122 exerts on the HCV internal ribosomalentry site (IRES), we developed an advanced Selective 2’-HydroxylAcylation analyzed by Primer Extension (SHAPE) method <strong>of</strong> analyzingRNA architecture. SHAPE determines RNA secondary structure atsingle-nucleotide resolution, with an accuracy far superior to othermapping methods. Using the above strategy, we show that binding <strong>of</strong>miR-122 to one <strong>of</strong> its target sites within the 5’ UTR <strong>of</strong> HCV induces aconformational shift in the HCV IRES at the distant AUG translation startsite. Surprisingly, binding <strong>of</strong> miR-122 to its second target site in HCVis mediated by a number <strong>of</strong> non-canonical base-pairings. Mutation <strong>of</strong>the 3’ half <strong>of</strong> miR-122 (tail) disrupted these non-canonical interactionsand its ability to induce a conformational shift at the AUG start site.We also observed that, in vitro, the first miR-122 target site in HCVis part <strong>of</strong> a putative triple-strand RNA motif. These results providethe first demonstration that the tail <strong>of</strong> this liver-encoded miRNA candirectly alter the RNA conformation <strong>of</strong> the HCV IRES, and therebyprovide new insights into the mechanism by which miR-122 influencesviral translation. We also show that the 5’ UTR <strong>of</strong> HCV contains a triplexstructure important for viral translation.Poster Abstracts<strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine • 79
- Page 7 and 8:
Meeting SponsorsThe Association of
- Page 9 and 10:
Registration ServicesRegistration S
- Page 12 and 13:
Presenter InformationPresenter Info
- Page 14 and 15:
AwardsABRF Annual Award for Outstan
- Page 16 and 17:
ABRF Robert A. Welch Outstanding Re
- Page 18 and 19:
Program-at-a-GlanceProgram-at-a-Gla
- Page 20 and 21:
Sunday, February 20 (Continued)(S1-
- Page 22 and 23:
Sunday, February 20 (Continued)(W3-
- Page 24 and 25:
Monday, February 21 (Continued)12:0
- Page 26 and 27:
Tuesday, February 22 (Continued)9:0
- Page 28 and 29:
Tuesday, February 22 (Continued)(W1
- Page 30 and 31: Satellite Educational Workshop Spon
- Page 32 and 33: SW2: An Introduction to Metabolomic
- Page 34 and 35: SW4: Lean Management in Core Facili
- Page 36 and 37: Plenary Session AbstractsPlenary Se
- Page 38 and 39: Scientific Session AbstractsScienti
- Page 40 and 41: Scientific SessionAbstractsstatisti
- Page 42 and 43: Scientific SessionAbstracts(S5) Hig
- Page 44 and 45: Scientific SessionAbstracts(S7-2) S
- Page 46 and 47: Workshop Session AbstractsWorkshop
- Page 48 and 49: Workshop SessionAbstractscase incor
- Page 50 and 51: Workshop SessionAbstracts(W7) Cellu
- Page 52 and 53: Workshop SessionAbstractsresolution
- Page 54 and 55: (W14-3) Galaxy Next Generation Sequ
- Page 56 and 57: Research Group Presentation Abstrac
- Page 58 and 59: Research GroupPresentation Abstract
- Page 60 and 61: Research GroupPresentation Abstract
- Page 62 and 63: Poster Session Abstracts**ABRF Post
- Page 64 and 65: Poster Abstractsglobal gene express
- Page 66 and 67: Poster Abstractsdiscussions of cont
- Page 68 and 69: Poster Abstractspossible applicatio
- Page 70 and 71: Poster Abstracts129 Bravo Automated
- Page 73 and 74: distribution. Additionally, we show
- Page 75 and 76: Illumina Genome Analyzer. PicoPlex
- Page 77 and 78: uniformity, reproducibility of enri
- Page 79: kits for Tempus TM and PAXgene® st
- Page 83 and 84: Phoenix crystallography robot and a
- Page 85 and 86: Laboratory is located next door and
- Page 87 and 88: data of a Thermo Orbitrap instrumen
- Page 89 and 90: **197 Multi-Functional Superparamag
- Page 91 and 92: pattern of N-linked glycans in form
- Page 93 and 94: advantage of using two separate 15
- Page 95 and 96: allowed absolute quantitation. Comp
- Page 97 and 98: levels between the animal groups. A
- Page 99 and 100: MuDPIT, and off-gel electrophoresis
- Page 101 and 102: 237 Multi-Site Assessment of Proteo
- Page 103 and 104: with good limits of quantification
- Page 105 and 106: 249 Rapid Monoclonal Antibody Glyca
- Page 107 and 108: OOng, J. - 117PPatel, S. - 169Peake
- Page 109 and 110: AnaSpec, Eurogentec Group Booth 417
- Page 111 and 112: FASEB MARC Program Booth 4169650 Ro
- Page 113 and 114: IntegenX, Inc. Booth 2015720 Stoner
- Page 115 and 116: Nonlinear Dynamics Booth 1052530 Me
- Page 117 and 118: Roche Applied Science Booth 5009115
- Page 119 and 120: Exhibit Hall FloorplanGrand Oaks Ba
- Page 121 and 122: Exhibitor List in Booth OrderExhibi
- Page 123 and 124: This workshop will present ways to
- Page 125 and 126: Grand Oaks Ballroom,Rooms P&Q, Leve
- Page 127 and 128: NotesNotesABRF 2011 — Technologie
- Page 129 and 130: Tuesday, February 22 — 12:00 pm -
- Page 131 and 132:
MARCH 16-20, 2012 • DISNEY’S CO